With Christmas fast approaching and people on the lookout for gift ideas, we have picked a selection of stocks that we think are ones to watch for the New Year and would make the perfect investment gift
ONE FOR THE ENVIRONMENTALLY CONSCIOUS:
Jubilee Metals Group plc (AIM: JLP | Mkt Cap: £77.2m):
WHO: A South African based, environmentally friendly metals recovery business currently in South Africa and Zambia (PGMs, chrome, lead, zinc, vanadium, copper, and cobalt).
WHY: Revenues are set to get a significant boost following the recent acquisition of all PGM (current and future) and chrome (current) earnings at its Inyoni Operations (South Africa) – this means Jubilee now has full control of the large-scale operation meaning earnings no longer have to be shared (annual results to 30 June ’19 showed a 67% growth to £23.6m and significant earnings growth of £7m).
BONUS: The metals are sourced from slag, slurry, mine tailings, waste and alternative secondary materials from mining operations ensuring a positive effect on the environment with a zero effluent policy.
ONE FOR THE ENGINEERING BUFFS:
Ferro-Alloy Resources Limited (LSE: FAR | Mkt Cap: £49.6m):
WHO: An emerging vanadium producer in a geographically advantageous area in Southern Kazakhstan.
WHY: FAR has the potential to be the world’s lowest-cost vanadium producer in a market where the demand for traditional (steel) and emerging (redox flow batteries) uses is ever-growing. The opportunity here is the huge Balasauqandiq Project, which is being developed in parallel with the Company’s existing profitable processing operation. With a simplified processing requirement reducing both capital and operating costs by about 60% compared to most other vanadium deposits and producers, Balasauqandiq has economic potential in a class of its own (NPV of $2 billion at a long-term forecast vanadium pentoxide price of $7.50/lb),
ONE FOR THE HEALTH HEROES:
MGC Pharmaceuticals Limited (ASX: MXC | Mkt Cap: $42.4m):
WHO: A European based bio-pharma company supplying phytocannabinoid derived medicines to patients globally.
WHY: Poised to be one of the first companies utilising cannabis for medicinal purposes to list on the LSE following the UK legalising the prescription of medicinal cannabis in November 2018. Alongside this the Company has strong growth plans: MGC Pharma is currently targeting three widespread medical conditions – epilepsy, dementia and IBS – and working on a number of research projects to extend this further. The company also has a growing patient base in Australia, the UK & Latin America, with a global distribution footprint via an extensive network of commercial partners, and is constructing a 15,720m2 GMP state of the art facility in Malta to meet growing global market demands.
ONE FOR THE SWEET-TOOTHED FANS:
Dekel Agri-Vision plc (AIM: DKL | Mkt Cap: £11.3m):
WHO: A multi-project, multi-commodity West African focused agriculture company that places smallholders at the heart of its operations.
WHY: With palm oil prices recovering from cyclical lows, a large-scale cashew processing plant due to come on stream, and a strengthened balance sheet thanks to a recently completed debt refinancing (with a UK govt backed social impact investor AgDevCo), 2020 is expected to see a major jump in Dekel’s revenues and profitability.
ONE FOR THE GOLD TRADITIONALISTS:
Cora Gold (AIM: CORA | Mkt Cap: £6.8m):
WHO: A gold exploration company with a portfolio of exploration assets in West Africa and an impressive gold team in tow having discovered over 8 million ounces in Africa between them.
WHY: Arguably one of the most exciting gold juniors listed on AIM thanks to its flagship Sanankoro project, which has been earmarked as offering a fast route into production. With a 1-2Moz exploration target area across some of West Africa’s best greenstone gold belts and a maiden resource due by the end of 2019, 2020 is set to be a busy year for this gold play.
ONE FOR THE TIPSTERS:
Bluejay Mining Plc (AIM: JAY | Mkt Cap: £72.4 million):
WHO: Greenland-centric Bluejay manages a portfolio of exploration, development and nearing-production assets.
WHY: The world’s highest-grade mineral sand ilmenite project – the Dundas Ilmenite Project – is well underway to becoming a commercially viable operation. A fruitful 2019 has seen Bluejay formalise an agreement with Rio Tinto Iron and Titanium Canada Inc. and raise £11.5 million (including £4 million from ventures backed by the local state), marking major progress as it awaits the final Mining Licence milestone. A testament to the company’s strong prospects, First Berlin Equity Research has given Bluejay a BUY recommendation with a target price of 21.8p, over double its current 8.5p price.
ONE FOR THE OIL & GAS ENTHUSIASTS
Empyrean Energy (AIM: EME | Market Cap: £37.8 million)
WHO: Oil & gas explorer focussed on three cornerstone assets with transformational potential: Block 29/11 offshore China; the Duyung PSC offshore Indonesia, and; a multi-project participating interest in the Sacramento Basin, California.
WHY: Empyrean just concluded a successful appraisal programme in Indonesia, delivering the potential for a significant resource upgrade. The Block 29/11 in China has undergone extensive geological work and has been de-risked comprehensively to drill-ready status. The geological chance of success is 33% and with a drill programme commencing in Q4 2020 the potential uplift for the company is tremendous. Cenkos has given the Company a BUY recommendation and a target price of 31p, more than 300% increase from the current price of 9p.
If you would be interested in speaking with any of the above management teams or would like any further information we would be more than happy to arrange.
Many thanks, Charlotte
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned